Annual Non Current Assets
$319.84 M
+$165.99 M+107.89%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual long term assets is $319.84 million, with the most recent change of +$165.99 million (+107.89%) on December 31, 2023.
- During the last 3 years, XENE annual non current assets has risen by +$312.43 million (+4220.36%).
- XENE annual non current assets is now at all-time high.
Performance
XENE Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$176.26 M
+$20.34 M+13.04%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly long term assets is $176.26 million, with the most recent change of +$20.34 million (+13.04%) on September 30, 2024.
- Over the past year, XENE quarterly non current assets has increased by +$20.34 million (+13.04%).
- XENE quarterly non current assets is now -44.89% below its all-time high of $319.84 million, reached on December 31, 2023.
Performance
XENE Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
XENE Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +107.9% | +13.0% |
3 y3 years | +4220.4% | +25.6% |
5 y5 years | +10000.0% | +25.6% |
XENE Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +2362.7% | -44.9% | +1316.6% |
5 y | 5-year | at high | >+9999.0% | -44.9% | +6126.1% |
alltime | all time | at high | >+9999.0% | -44.9% | >+9999.0% |
Xenon Pharmaceuticals Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $176.26 M(+13.0%) |
Jun 2024 | - | $155.92 M(-26.4%) |
Mar 2024 | - | $211.82 M(-33.8%) |
Dec 2023 | $644.96 M(+7.4%) | $319.84 M(+128.3%) |
Sep 2023 | - | $140.09 M(-0.1%) |
Jun 2023 | - | $140.28 M(-24.8%) |
Mar 2023 | - | $186.52 M(+21.2%) |
Dec 2022 | $600.30 M(+7.4%) | $153.85 M(+21.5%) |
Sep 2022 | - | $126.64 M(+906.9%) |
Jun 2022 | - | $12.58 M(+1.1%) |
Mar 2022 | - | $12.44 M(-4.2%) |
Dec 2021 | $559.02 M(+207.5%) | $12.99 M(+61.5%) |
Sep 2021 | - | $8.04 M(+1.0%) |
Jun 2021 | - | $7.96 M(+7.4%) |
Mar 2021 | - | $7.41 M(+0.1%) |
Dec 2020 | $181.78 M(+25.5%) | $7.40 M(+71.4%) |
Sep 2020 | - | $4.32 M(+17.8%) |
Jun 2020 | - | $3.67 M(+15.5%) |
Mar 2020 | - | $3.17 M(+12.1%) |
Dec 2019 | $144.87 M | $2.83 M(+16.7%) |
Sep 2019 | - | $2.43 M(-5.5%) |
Jun 2019 | - | $2.57 M(+2.6%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $2.50 M(+128.4%) |
Dec 2018 | $121.33 M(+170.7%) | $1.10 M(+13.9%) |
Sep 2018 | - | $962.00 K(-11.4%) |
Jun 2018 | - | $1.09 M(-1.4%) |
Mar 2018 | - | $1.10 M(-15.3%) |
Dec 2017 | $44.82 M(-31.8%) | $1.30 M(-5.2%) |
Sep 2017 | - | $1.37 M(-13.9%) |
Jun 2017 | - | $1.59 M(-3.2%) |
Mar 2017 | - | $1.65 M(-9.2%) |
Dec 2016 | $65.67 M(+7.9%) | $1.81 M(-10.3%) |
Sep 2016 | - | $2.02 M(-11.9%) |
Jun 2016 | - | $2.29 M(-20.4%) |
Mar 2016 | - | $2.88 M(-6.5%) |
Dec 2015 | $60.87 M(-28.3%) | $3.08 M(-19.5%) |
Sep 2015 | - | $3.83 M(+76.2%) |
Jun 2015 | - | $2.17 M(-7.6%) |
Mar 2015 | - | $2.35 M(-5.0%) |
Dec 2014 | $84.94 M(+70.3%) | $2.48 M(-57.9%) |
Sep 2014 | - | $5.88 M(+6.7%) |
Jun 2014 | - | $5.50 M(+19.2%) |
Dec 2013 | $49.87 M(-17.8%) | $4.62 M |
Dec 2012 | $60.70 M | - |
FAQ
- What is Xenon Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual non current assets year-on-year change?
- What is Xenon Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly non current assets year-on-year change?
What is Xenon Pharmaceuticals annual long term assets?
The current annual non current assets of XENE is $319.84 M
What is the all time high annual non current assets for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual long term assets is $319.84 M
What is Xenon Pharmaceuticals annual non current assets year-on-year change?
Over the past year, XENE annual long term assets has changed by +$165.99 M (+107.89%)
What is Xenon Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of XENE is $176.26 M
What is the all time high quarterly non current assets for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly long term assets is $319.84 M
What is Xenon Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, XENE quarterly long term assets has changed by +$20.34 M (+13.04%)